Dal Pan GJ - Search Results

1

Systemic Corticosteroid Use for COVID-19 in US Outpatient Settings From April 2020 to August 2021.

Bradley MC, Perez-Vilar S, Chillarige Y, Dong D, Martinez AI, Weckstein AR, Dal Pan GJ. Bradley MC, et al. Among authors: dal pan gj. JAMA. 2022 May 24;327(20):2015-2018. doi: 10.1001/jama.2022.4877. JAMA. 2022. PMID: 35394487 Free PMC article.

2

A COVID-19-ready public health surveillance system: The Food and Drug Administration's Sentinel System.

Cocoros NM, Fuller CC, Adimadhyam S, Ball R, Brown JS, Dal Pan GJ, Kluberg SA, Lo Re V 3rd, Maro JC, Nguyen M, Orr R, Paraoan D, Perlin J, Poland RE, Driscoll MR, Sands K, Toh S, Yih WK, Platt R; And the FDA-Sentinel COVID-19 Working Group. Cocoros NM, et al. Among authors: dal pan gj. Pharmacoepidemiol Drug Saf. 2021 Jul;30(7):827-837. doi: 10.1002/pds.5240. Epub 2021 Apr 18. Pharmacoepidemiol Drug Saf. 2021. PMID: 33797815 Free PMC article. Review.

3

Gauging the Effectiveness of Medicines Safety Communications From Global Regulatory Agencies.

Dal Pan GJ. Dal Pan GJ. JAMA Intern Med. 2019 Jul 1;179(7):984-985. doi: 10.1001/jamainternmed.2019.0266. JAMA Intern Med. 2019. PMID: 31034034 No abstract available.

4

Patterns of opioid analgesic use in the U.S., 2009 to 2018.

Woods C, Chai G, Meyer T, Staffa J, Dal Pan G. Woods C, et al. Pain. 2021 Apr 1;162(4):1060-1067. doi: 10.1097/j.pain.0000000000002101. Pain. 2021. PMID: 33021566

5

The Impact of Variability in Patient Exposure During Premarket Clinical Development on Postmarket Safety Outcomes.

Cherkaoui S, Pinnow E, Bulatao I, Day B, Kalaria M, Brajovic S, Dal Pan G. Cherkaoui S, et al. Clin Pharmacol Ther. 2021 Dec;110(6):1512-1525. doi: 10.1002/cpt.2320. Epub 2021 Jul 8. Clin Pharmacol Ther. 2021. PMID: 34057195 Free PMC article.

6

Sources of Evidence Triggering and Supporting Safety-Related Labeling Changes: A 10-Year Longitudinal Assessment of 22 New Molecular Entities Approved in 2008 by the US Food and Drug Administration.

Croteau D, Pinnow E, Wu E, Muñoz M, Bulatao I, Dal Pan G. Croteau D, et al. Drug Saf. 2022 Feb;45(2):169-180. doi: 10.1007/s40264-021-01142-3. Epub 2022 Feb 3. Drug Saf. 2022. PMID: 35113347

7

New Opioid Analgesic Approvals and Outpatient Utilization of Opioid Analgesics in the United States, 1997 through 2015.

Chai G, Xu J, Osterhout J, Liberatore MA, Miller KL, Wolff C, Cruz M, Lurie P, Dal Pan G. Chai G, et al. Anesthesiology. 2018 May;128(5):953-966. doi: 10.1097/ALN.0000000000002187. Anesthesiology. 2018. PMID: 29557812 Free article.

8

Patient-Reported Opioid Analgesic Use After Discharge from Surgical Procedures: A Systematic Review.

Mallama CA, Greene C, Alexandridis AA, McAninch JK, Dal Pan G, Meyer T. Mallama CA, et al. Pain Med. 2022 Jan 3;23(1):29-44. doi: 10.1093/pm/pnab244. Pain Med. 2022. PMID: 34347101

9

The Food and Drug Administration's (FDA's) Drug Safety Surveillance During the COVID-19 Pandemic.

Diak IL, Swank K, McCartan K, Beganovic M, Kidd J, Gada N, Kapoor R, Wolf L, Kangas L, Wyeth J, Salvatore T, Fanari M, LeBoeuf AA, Mishra P, Blum MD, Dal Pan G. Diak IL, et al. Drug Saf. 2023 Feb;46(2):145-155. doi: 10.1007/s40264-022-01256-2. Epub 2022 Dec 2. Drug Saf. 2023. PMID: 36460854 Free PMC article.

10

Postmarket Safety Outcomes for New Molecular Entity (NME) Drugs Approved by the Food and Drug Administration Between 2002 and 2014.

Pinnow E, Amr S, Bentzen SM, Brajovic S, Hungerford L, St George DM, Dal Pan G. Pinnow E, et al. Clin Pharmacol Ther. 2018 Aug;104(2):390-400. doi: 10.1002/cpt.944. Epub 2017 Dec 20. Clin Pharmacol Ther. 2018. PMID: 29266187

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters